BSE Live
Jan 02, 16:01Prev. Close
72.69
Open Price
73.01
Bid Price (Qty.)
72.15 (10)
Offer Price (Qty.)
78.00 (10)
NSE Live
Jan 05, 12:28Prev. Close
73.25
Open Price
73.50
Bid Price (Qty.)
72.73 (6)
Offer Price (Qty.)
73.49 (3)
| Cash Flow of Bal Pharma (in Rs. Cr.) | Mar 05 | Mar 04 | |
| 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 2.20 | 3.09 | |
| Net CashFlow From Operating Activities | 0.09 | 1.49 | |
| Net Cash Used In Investing Activities | -3.93 | -2.59 | |
| Net Cash Used From Financing Activities | 4.41 | 1.07 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.57 | -0.03 | |
| Cash And Cash Equivalents Begin of Year | 0.77 | 0.80 | |
| Cash And Cash Equivalents End Of Year | 1.33 | 0.77 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y